tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

ALMS Stock Latest News

Alumis Inc. Advances Pipeline Amid Financial Challenges
Company AnnouncementsAlumis Inc. Advances Pipeline Amid Financial Challenges
30d ago
ALMS
Alumis reports Q3 revenue $2.07M, consensus $3.14M
PremiumThe Fly
Alumis reports Q3 revenue $2.07M, consensus $3.14M
30d ago
ALMS
ALMS Earnings this Week: How Will it Perform?
PremiumPre-Earnings
ALMS Earnings this Week: How Will it Perform?
1M ago
ALMS
Alumis Inc.’s ESK-001 Study: A Potential Game-Changer in Psoriasis Treatment
PremiumCompany Announcements
Alumis Inc.’s ESK-001 Study: A Potential Game-Changer in Psoriasis Treatment
2M ago
ALMS
Alumis Inc.’s ESK-001 Study: A Potential Game-Changer for Renal Impairment Treatment
PremiumCompany Announcements
Alumis Inc.’s ESK-001 Study: A Potential Game-Changer for Renal Impairment Treatment
2M ago
ALMS
Alumis Inc.’s ESK-001 Study: A Potential Game-Changer for Hepatic Impairment Treatment?
PremiumCompany AnnouncementsAlumis Inc.’s ESK-001 Study: A Potential Game-Changer for Hepatic Impairment Treatment?
2M ago
ALMS
Alumis Inc. Updates Corporate Presentation on Pipeline
Premium
Company Announcements
Alumis Inc. Updates Corporate Presentation on Pipeline
3M ago
8K
ALMS
Alumis Inc. Reports Q2 2025 Earnings and Strategic Advances
Premium
Company Announcements
Alumis Inc. Reports Q2 2025 Earnings and Strategic Advances
4M ago
ALMS
ALMS Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
ALMS Earnings Report this Week: Is It a Buy, Ahead of Earnings?
4M ago
ALMS
Alumis Inc.: Strong Buy Rating Backed by Promising Drug Candidate and Strategic Positioning
PremiumRatings
Alumis Inc.: Strong Buy Rating Backed by Promising Drug Candidate and Strategic Positioning
4M ago
ALMS
Alumis reports Q2 revenue $2.67M, consensus $2.43M
PremiumThe Fly
Alumis reports Q2 revenue $2.67M, consensus $2.43M
4M ago
ALMS
Alumis Inc. Concludes 2025 Annual Stockholders Meeting
PremiumCompany Announcements
Alumis Inc. Concludes 2025 Annual Stockholders Meeting
4M ago
8K
ALMS
Alumis Inc.: Promising Pipeline and Strategic Advancements Justify Buy Rating
PremiumRatingsAlumis Inc.: Promising Pipeline and Strategic Advancements Justify Buy Rating
5M ago
ALMS
Alumis initiated with an Overweight at Wells Fargo
Premium
The Fly
Alumis initiated with an Overweight at Wells Fargo
5M ago
ALMS
Alumis Inc.: Buy Rating Affirmed Amid Promising ESK-001 Developments and Strong Financial Projections
Premium
Ratings
Alumis Inc.: Buy Rating Affirmed Amid Promising ESK-001 Developments and Strong Financial Projections
5M ago
ALMS
Alumis completes patient enrollment in global LUMUS Phase 2b trial of ESK-001
PremiumThe Fly
Alumis completes patient enrollment in global LUMUS Phase 2b trial of ESK-001
5M ago
ALMS
Alumis promotes Sanam Pangali to chief legal officer
PremiumThe Fly
Alumis promotes Sanam Pangali to chief legal officer
5M ago
ALMS
Alumis files $400M mixed securities shelf
PremiumThe Fly
Alumis files $400M mixed securities shelf
5M ago
ALMS
Largest borrow rate increases among liquid names
PremiumThe Fly
Largest borrow rate increases among liquid names
6M ago
RDW
ALMS
Alumis resumed with a Buy at Guggenheim
PremiumThe FlyAlumis resumed with a Buy at Guggenheim
6M ago
ALMS
Largest borrow rate increases among liquid names
Premium
The Fly
Largest borrow rate increases among liquid names
6M ago
VG
RDW
Alumis resumed with an Overweight at Morgan Stanley
Premium
The Fly
Alumis resumed with an Overweight at Morgan Stanley
6M ago
ALMS

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >